Tuesday, April 30, 2019

Procalcitonin Antibody Market Size,Status and Forecast 2026

Procalcitonin (PCT) is a peptide precursor of the calcitonin hormone. Procalcitonin is a peptide that contains 116 amino acids and has an estimated molecular weight of 14.5 kDa. It can be separated into three parts: immature calcitonin, amino terminus of the PCT region, and calcitonin carboxyl-terminus peptide-1. In 1970, procalcitonin was first classified by Leonard J. Deftos and Bernard Roos. It is produced by endocrine cells of the lung and by C cells of the thyroid. The level of procalcitonin rises in the human body due to injury, shock, or bacterial infection, which increases the production of procalcitonin, resulting in organ dysfunction. The level of procalcitonin in the body can be diagnosed with wet lab analysis using procalcitonin antibody.
The global procalcitonin antibody market is expected to be driven by rise in prevalence of chronic diseases such as sepsis, hepatitis, tuberculosis, and HIV. According to the World Health Organization (WHO), cancer accounted for 8.8 million deaths and HIV related illnesses accounted for around 1.0 million deaths globally in 2015. Procalcitonin antibody is used as a marker to improve identification of bacterial infections and develop antibiotic therapies. This is expected to drive the procalcitonin antibody market. Moreover, increase in funding for research and development by major players and government initiatives for the development of safer, efficient, and innovative products for the treatment of diseases such as cancer boost the growth of the global procalcitonin antibody market. For instance, in 2018, the U.S. Government approved US$ 3 Bn fund for the National Institutes of Health’s research and development activities.
The global procalcitonin antibody market can be segmented based on antibody type, end-user, and region. In terms of antibody type, the global procalcitonin antibody market can be bifurcated into polyclonal procalcitonin antibody and monoclonal procalcitonin antibody. Based on end-user, the global procalcitonin antibody market can be classified into hospitals, research institutes, and others. In terms of region, the global procalcitonin antibody market can be segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region can be divided into specific countries/sub-regions such as the U.S., Canada, the U.K., Germany, Brazil, China, India, and GCC Countries. North America dominated the global procalcitonin antibody market in 2017 because of increase in adoption of new techniques in research and rise in health care spending. According to the U.S. Centers for Medicare & Medicaid Services, national health care spending is projected to increase at an average rate of 5.5% per year from 2017 to 2026 to reach around US$ 5.7 Trn by 2026. Asia Pacific is considered to be the most attractive market for procalcitonin antibody during the forecast period due to surge in health awareness and demand for advanced medical technology.
Key players operating in the global procalcitonin antibody market are bioMérieux SA, HyTest Ltd., F. Hoffmann-La Roche Ltd., Shenzhen New Industries Biomedical Engineering Co., Ltd., Thermo Fisher Scientific, Vazyme Biotech Co., Ltd., Hotgen Biotech Co., Ltd., and Hangzhou Realy Tech Co., Ltd., among others. These players have adopted strategies such as collaborations, agreements, partnerships, and new product launches to gain competitive advantage in the procalcitonin antibody market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Posted by at No comments:

Protein Binding Assays Market: Shares, Strategies and Forecasts, Analysis and Overview upto 2026

Global Protein Binding Assays Market: Overview
Protein binding assays are used for measuring the interactions or affinity of reactions between a protein molecule to another protein or to nuclei acid. Understanding of such interactions is important in assessing the distribution potential of a compound or drug molecule in the tissues within the body. The demand for protein binding assays with the use of assays of reliable performance is gaining traction in cellular and molecular biology and in understanding various biochemical mechanisms. The study has been receiving attention by researchers and industry players as the assay helps in improving the therapeutic effects of compounds and also helps to reduce the amount of target molecule. The data from the protein binding assays is used in predicting the pharmacokinetics of a compound.
Scientific literature abounds to guide how binding reactions need to be carried out at equilibrium and how to make judicious use of precious reagent. In addition, researchers using these assays carefully plan binding experiments in the lab to get optimal output, thus pointing the significance of a well-panned experiment to reap the maximum gains. Some of the key end users of protein binding assays are contract research organizations consulting firms, and pharmaceutical and biotech companies. Some of the key technologies used are equilibrium dialysis, ultracentrifugation, and ultrafiltration.
The elaborate assessment of the outlook and emerging contours of the global protein binding assays market is an indispensable guide to interested market participants for getting an in-depth and clear understanding of the demand dynamics.
Global Protein Binding Assays Market: Trends and Opportunities
Burgeoning drug making activities by pharmaceutical and biotechnology companies in various regions across the globe is a key factor driving the demand for protein binding assays. The trend is increasingly propelled by the rising demand for novel drugs and advanced drug therapies for chronic and hard-to-treat diseases. The staggering rise in number of drug candidates in the pipeline is a notable factor catalyzing the need for better protein binding assays. The global protein binding assays market has gained a rapid momentum from the growing need for optimizing drug discovery costs, mainly by avoiding costly drug failures. This has increased the focus of industry players in improving the return on investment on preclinical processes in drug making processes. Protein binding assays are gaining traction among pharmaceutical processes or preventing late-stage attrition in drug discovery.
Rising research and development spends on novel drugs discovery by public and private organizations in developing regions are expanding the prospects of the protein binding assays market. Moreover, the growing role of contract research organizations in drug discovery initiatives has been creating several exciting avenues for protein binding assays market players to capitalize on. However, in recent years, the protein binding assays has not been able to realize the full potential owing to limitations with the existing assay technologies and the lack of clinical expertise in designing binding experiments.
Global Protein Binding Assays Market: Regional Outlook
The report offers a critical assessment of lucrative avenues in key regions and the insights focus on the favorable investment developments in various regions. Geographically, developing and developed regions will play an increasingly vital role in the growth dynamics of the protein binding assays market. In particular, North America is potentially lucrative region, driven increasingly by substantial spends by pharmaceutical industries.
Key Players Mentioned in the Report
Several prominent players in the protein binding assays market are focusing on both organic and inorganic strategies for growth. The study takes a critical look at product development spends of established players. Some of the key players aiming at higher stakes in the protein binding assays market are Thermo Fisher Scientific, GE Healthcare, Merck, and Danaher.
Posted by at No comments:

Andersen-Tawil Syndrome Diagnostic and Treatment Market Size, Status and Forecast to 2026

The Andersen-Tawil syndrome is rare genetic disorder. It is also known as the Andersen syndrome or long QT syndrome 7. It is a rare genetic disorder characterized by a distinctive pattern of features such as episodes of muscle weakness, differences in facial and body structure, and certain kinds of heart rhythm disturbances. According to the Genetic and Rare Diseases Information Center, approximately 60% of cases of the syndrome are caused by mutations in the KCNJ2 gene.
Signs and symptoms of Anderson-Tawil syndrome include muscle weakness, developmental abnormalities, and changes in heart rhythm. Physical abnormalities associated with the syndrome include very small lower jaw, low-set ears, unusual curving of the fingers, and an abnormal curvature of the spine. Symptoms generally appear between the ages of 20 and 22 years.
Andersen-Tawil syndrome is diagnosed based on some of identification of characteristic symptoms such as symptomatic arrhythmias, skeletal features, and periodic paralysis. Electrocardiogram or EKG and long exercise nerve conduction studies are also used to diagnose the Andersen-Tawil syndrome.
Increase in the prevalence of Andersen-Tawil syndrome worldwide is anticipated to boost the Andersen-Tawil Syndrome diagnostic and treatment market during the forecast period. A rise in government prioritization of drugs for rare disorders is also likely to boost the market in the near future. However, lack of knowledge about the Andersen-Tawil syndrome is a major restraint of the market. Moreover, a dearth of health care experts in Latin America and Middle East & Africa limits the growth of the Andersen-Tawil Syndrome diagnostic and treatment market in the regions. Nevertheless, increased government funding for diagnosis procedures is likely to offer attractive opportunities for the Andersen-Tawil Syndrome diagnostic and treatment market. Organizations supporting the treatment of this disease globally are Muscular Dystrophy UK, Periodic Paralysis International, Periodic Paralysis Association, and Sudden Arrhythmia Death Syndromes Foundation.
The global Andersen-Tawil syndrome diagnostic and treatment market can be segmented based on treatment, diagnostic test, end-user, and region. In terms of treatment, the market can be classified into carbonic anhydrase inhibitors and beta-blockers. Acetazolamide, dichlorpenamide, aldactone and dyrenium are common carbonic anhydrase inhibitors drugs used for the treatment of Andersen-Tawil syndrome. Beta-blockers such as atenolol have been successfully used in some patients as per PubMed research studies.
Based on diagnostic test, the market can be classified into physical test and genetic test.
In terms of end-user, the global Andersen-Tawil Syndrome diagnostic and treatment market can be categorized into hospitals and others. The hospitals segment held a prominent share of the market in 2017.
Based on region, the global Andersen-Tawil syndrome diagnostic and treatment market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue. The Andersen-Tawil syndrome diagnostic and treatment market in Asia Pacific is expanding rapidly due to an increase in the number of patients suffering from the disorder in the region. Factor such as better health care infrastructure, economic growth, rise in the number of insurance payers, expanding and developing private health care sector, and increase in awareness among people regarding Andersen-Tawil syndrome diagnostic and treatment are expected to propel the market in the region in the next few years. The Andersen-Tawil Syndrome diagnostic and treatment market in Latin America and Middle East & Africa is projected to expand at a moderate growth rate from 2018 to 2026.
Key players operating in the global Andersen-Tawil Syndrome diagnostic and treatment market include Teva Pharmaceutical Industries Ltd., Zydus Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Advanz Pharmaceutical, Mylan N.V., and Novartis AG.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:

Calcium Tablets Market Competitive Landscape Analysis with Forecast by 2026

Food security is necessary for human wellbeing and a dominant constituent of the Millennium Development Goals (MDGs) of the United Nations. The concern of the micro and macro-nutrient components of the diet and food safety occurs when all people, have economic, social, and physical access to adequate safe and  nutritious food that fulfills food preferences for an active and healthy life and their dietary needs. Calcium is the most important mineral required to maintain bone health in the human body and is best known for its vital role in preventing osteoporosis. Calcium also helps to maintain and build a strong skeletal structure. Moreover, it plays an important role in cell-signaling pathways as a messenger throughout the body and is necessary for transmission of nerve signals, secretion of hormones, normal cell function, blood coagulation, muscle relaxation, and muscle contraction. Calcium deficiency indications may include transmission of nerve signals, secretion of hormones, normal cell function, blood coagulation, muscle relaxation, and muscle contraction any of these functions and visible in a number of ways.
The global calcium tablets market can be segmented based on type of calcium, dosage form, and distribution channel. In terms of type of calcium, the global calcium tablets market can be classified into calcium carbonate, calcium citrate, oyster shell calcium, calcium gluconate, calcium lactate, calcium phosphate, calcium citrate malate, and calcium orotate. Calcium carbonate and calcium citrate are the two major types of calcium. Calcium carbonate is the cheapest and therefore often a good first choice. Common calcium supplements may be labeled as calcium carbonate (40% elemental calcium), calcium gluconate (9% elemental calcium), calcium citrate (21% elemental calcium), and calcium lactate (13% elemental calcium). Based on dosage form, the global calcium tablets market can be categorized into effervescent tablets, chewable tablets, sublingual tablets, and enteric coated tablets. Effervescent calcium tablets have been gaining attention in the market. These tablets allow complete ionization and dissolution of calcium by dissolving in water, and significantly increase absorption in the digestive track. Moreover, the large size of effervescent calcium tablets have made these a more convenient form of calcium supplement. Chewable tablets are usually preferred for kids and adults due to large size. These are flavored tablets and good to taste. Sublingual tablets are kept below the tongue, and are quickly absorbed through this route. Enteric coated tablets are slow release tablets.
In terms of distribution channel, the global calcium tablets market can be divided into retail pharmacies, online pharmacies, hospital pharmacies, and others. The retail pharmacies segment is expected to gain calcium tablets market share during the forecast period. Calcium tablets are also available over-the-counter. These fall under nutrition tablets category and are easily available in retail pharmacies and do not require physician prescription.
Geographically, the global calcium tablets market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is projected to account for the largest calcium tablets market share during the forecast period owing to high awareness about health supplements. Europe is anticipated to be the second largest market for calcium tablets by 2026. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period, owing to rise in government initiatives to spread awareness about calcium supplements and diseases caused due to its deficiency. Low price of calcium supplements is expected to boost the growth of the calcium tablets market in Latin America and Middle East & Africa from 2018 to 2026.
Key players in the global calcium tablets market are Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Pfizer, Inc. Lifezen Healthcare Pvt. Ltd., Boehringer Ingelheim GmbH, and Cipla Inc., among others.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Posted by at No comments:

High Volume Dispensing Systems Market: Emerging Trends, Business Growth Opportunities, Major Driving Factors

Global High Volume Dispensing Systems Market: Overview
High volume dispensing systems are cabinets for handling and provision of large volume medication inventory. Technological advancements and growing adoption of automation in the healthcare sector coupled with high adoption of the software in the high volume dispensing are fuelling growth of the global high volume dispensing systems market.
The high volume dispensing systems market dynamics show the current scenario along with growth and opportunities in the global high volume dispensing systems market. One of the key parts of the report is competitive analysis. It represents the impartial view of the competitive vendor landscape along with the profiles of key players operating in the global high volume dispensing systems market.
Global High Volume Dispensing Systems Market: Drivers and Restraints
Growing demand for prescribed drugs and rising cases of numerous diseases such as non-communicable diseases are supporting the growth of the global high volume dispensing systems market. Additionally, a growing number of people suffering from chronic health conditions is supporting the growth of the global high volume dispensing systems market. In addition, growing technological advancements for improving structural designing and automation of cabinets are leading to an increasing number of prescriptions are likely to boost demand for the high volume dispensing systems market.
The rising number of retail pharmacies and requirement for efficient systems such as software for automating the operation of high volume dispensing systems is boosting the growth of the high volume dispensing systems market. Moreover, the medical sector is trying to reduce the cost of medications and healthcare. This need for cost-cutting is augmenting adoption of the software and automation systems is boosting the growth of the global high volume dispensing systems market.
Furthermore, the government is increasingly funding the installation of an automated cabinet is augmenting adoption of high volume dispensing systems and likely to propel growth of the high volume dispensing systems market.
Global High Volume Dispensing Systems Market: Geographical Analysis
On the basis of region, the high volume dispensing systems market could be segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. Of these regions, North America is expected to dominate the global market for high volume dispensing systems owing to the presence of numerous key players in the region. Additionally, growing investment in the healthcare sector for offering advanced facilities is fuelling growth of the region. However, Asia Pacific is expected to expand with higher CAGR owing to growing  investment for improvement of the healthcare sector.
Global High Volume Dispensing Systems Market: Companies Mentioned
Some of the key players operating in the high volume dispensing systems market are Omnicell, Inc., Innovation Associates, McKesson Corporation, TCGRx, and ScriptPro, LLC. These companies are adopting the activities for growth such as collaborations, and partnerships for contributing higher share in the revenue of the global high volume dispensing systems market. 
Posted by at No comments:

Cognitive and Memory Enhancer Drugs Market Key Manufacturers, Development Trends And Competitive Analysis 2026

Global Cognitive and Memory Enhancer Drugs Market: Overview
The global market for cognitive and memory enhancer drugs market likely to witness significant growth owing to rising prevalence to improve individual health through improving memory and cognitive function of the geriatric populations all across the globe. The increasing competition among the society are another factor fueling demand for the global cognitive and memory enhancer drugs market. This helps in improving the memory focus and creativity among the populations. This can be one of the important factor boosting growth of this market across the globe.
The global market for cognitive and memory enhancer drugs market could see classification into drug type, application and on the basis of geography. Based on the drug type, the Namenda segment dominates the global market for cognitive and memory enhancer drug.
The report present complete analysis of the global cognitive and memory enhancer drug market, which includes regional analysis, market competition and segmental analysis.
Global Cognitive and Memory Enhancer Drugs Market: Trends and Opportunities 
Rising case of geriatric population and neurological disorders are one the important factor triggering growth of the cognitive and memory enhancer drugs market in coming years. According to WHO, around more than 46 million population live with dementia is another important factor influencing growth of this market. Moreover, large scale population adopting the cognitive and memory enhancer drugs can be one of the key factor supporting growth of this market in near future. Furthermore, ongoing clinical trials and potential drugs in pipeline are some of the other factor strengthening growth of this market in near future.
The global cognitive and memory enhancer drugs are mainly utilized to treat the patients suffering from schizophrenia, Alzheimer’s disease, stroke, aging and attention deficit hyperactivity disorder. The aforementioned factor are some of the key factor boosting growth of this market. The benefit associated with the  global cognitive and memory enhancer drugs are another factor driving growth of this market in near future. As per Alzheimer’s Research UK, among 2 in 100 population suffer from dementia which further raised to 1 in 5, this can be another major factor attributing growth of this market at global level.
In contrast, high cost involve in the research and development activities of the drugs and legal and ethical contradiction are some of the major factor negatively impacting growth of the global cognitive and memory enhancer drugs market in coming years. 
Global Cognitive and Memory Enhancer Drugs Market: Regional Outlook 
From a geographical point of view, the global market for cognitive and memory enhancer drug is bifurcated into Middle East and Africa, North America, Latin America, and Asia Pacific. Among these segment, North America dominates the global cognitive and memory enhancer drug market and generate highest market share in 2017. Which is further followed by Europe. Asia Pacific is likely to witness significant growth in terms of adoption. This can be one of the important factor driving growth. Also, Asia Pacific is emerging economies and likely to offer significant growth opportunity in near future. Furthermore, Latin America and Middle East and Africa likely to witness moderate growth in terms of usage.
Global Cognitive and Memory Enhancer Drugs Market: Companies Mentioned 
This portion of the report highlights prominent players operating in the global market for cognitive and memory enhancer drugs market. The research study also includes some of the major players operating in the global market for cognitive and memory enhancer drugs such as Johnson & Johnson, Pfizer Inc., Novartis AG, Eisai Co., Ltd., Cephalon, Inc. (Teva Pharmaceutical Industries Ltd., AlternaScript LLC, and Shire. The prominent players are highly focused toward the research and development activities in order to develop new drugs for the betterment of the patients.
Posted by at No comments:

Flexible & Semi-rigid Ureteroscopy Market Scope and Opportunities Analysis 2018 - 2026

Global Flexible & Semi-rigid Ureteroscopy Market: Overview
The report details an exhaustive account of the global flexible & semi-rigid ureteroscopy market along with numerous associated factors. Some of these factors that are included in the report are drivers, restraints, competitive analysis, latest trends and opportunities, geographical outlook, and many other aspects. The study covered in the report spans a forecast period from 2018 to 2028. From an overall perspective, the report is expected to exist as a valuable insight to businesses which are already operating in the global flexible & semi-rigid ureteroscopy market, as well for those who intend to newly establish themselves in this environment.
Global Flexible & Semi-rigid Ureteroscopy Market: Market Potential
Rising geriatric population is majorly responsible for propelling growth in the global flexible and semi-rigid ureteroscopy market. This is mainly due to the prevalence of urinary infections in old-aged people that demands use of necessary treatments. Furthermore, extensive technological advancements occurring in the field of medical technology are making several healthcare institutions use latest ureteroscope devices, thereby bolstering the market’s presence. A notable demand for better treatment-based accuracy is also driving growth in the global flexible and semi-rigid ureteroscopy market. This is mainly due to a high rate of efficiency associated with the use of these devices. Such a demand for better efficiency has led to several healthcare specialists prefer use flexible ureteroscopes compared to other alternatives. With healthcare infrastructures expected to extensively improve in future, the global flexible and semi-rigid ureteroscopy market is anticipated to post a fantastic growth in the next few years.
Global Flexible & Semi-rigid Ureteroscopy Market: Geographical Outlook
This market is mainly spread across North America, Asia Pacific, the Middle East and Africa, Europe, and Latin America. Of these, maximum presence of this domain is witnessed in North America thanks to a strong healthcare industry present in this region. Moreover, a high prevalence of kidney stones coupled with a large number of surgeries performed each year associated with urinary disorders too is pushing the market to attain splendid growth in North America. Moreover, avast presence of local and well-established market players coupled with implementation of healthy initiatives carried out by government in the region is encouraging use of flexible and semi-rigid ureteroscopes. These are prime factors that are stoking large-scale progress in the global flexible and semi-rigid ureteroscopy market in North America.
Global Flexible & Semi-rigid Ureteroscopy Market: Competitive Landscape
This market depicts the presence of a highly competitive vendor landscape owing to the presence of both new players as well as well-established companies. Most players are focusing on improving their service and treatment efficiency, facilitating product upgrades, and participating in mergers & acquisitions and partnerships, to improve their stance in this market. Olympus, Stryker, Boston Scientific, KARL STORZ, Richard Wolf, ELMED Medical Systems,  Rocamed, Maxer Endoscopy, ProSurg, and Vimex Endoscopy, are key players operating in the global flexible & semi-rigid ureteroscopy market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:

Friday, April 26, 2019

Angiography Tables Market Emerging Technologies, Regional Trends, Competitive Landscape, Regional Analysis & Forecasts to 2026

Cardiovascular diseases are the leading cause of death globally. Various treatments and technologies have been developed for prevention, detection, diagnosis, and treatment of these diseases. Angiography is a medical imaging technique used to visualize the blood vessels and body organs, especially veins, arteries, and heart chambers. Generally, this technique is performed to determine whether coronary arteries are blocked or functioning properly. Various tools and devices are required for angiography. Angiograph table is a key equipment used for angiography. These tables are useful for the entire procedure.
Rise in prevalence of coronary artery diseases, increase in cases of blockage in blood vessels generally in geriatric population, and surge in obesity across the world are the major factors driving the global angiography tables market. According to WHO, cardiovascular diseases accounted for an estimated 17.9 million deaths in 2016, which was 31% of overall global deaths; majority of these were coronary heart diseases. According to the American Heart Association, in the U.S. 43.8% of total cardiovascular disease deaths were due to coronary heart diseases in 2018. According to WHO, at least 2.8 million people die each year due to overweight or obesity. This overweight condition adversely affects human metabolic process hence cause disorders related with blood pressure, cholesterol, triglycerides and insulin resistance. These cause coronary heart diseases, stroke, and diabetes. Increase in per capita health expenditure, rise in awareness among people about heart diseases, and high investment by key players in emerging markets also drive the global angiography tables market. However, lower capital investment in patient handling, diagnostic equipment, and accessories by end-users in underdeveloped nations and rise in use of refurbished tables in the market are the major factors restraining the global angiography tables market.
The global angiography tables market can be segmented based on type, end-user, and region. In terms of type, the global angiography tables market can be divided into height-adjustable, tilting, and mobile. The height-adjustable segment dominated the global angiography tables market in 2017 owing to advantages such as flexibility and ease of operation. Based on end-user, the global angiography tables market can be classified into hospitals, diagnostic centers, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2017 and the trend is likely to continue during the forecast period. This is attributed to the availability of multiple service options and devices in hospitals, advanced technology, and tie-ups with health care companies to enhance service offerings.
In terms of region, the global angiography tables market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2017, followed by Europe. Rise in prevalence of coronary heart diseases, well-developed health care infrastructure, and better reimbursement policies for cardiovascular diseases drive the angiography tables market in the region. The angiography tables market in Asia Pacific is expected to expand at the highest CAGR during the forecast period due to increase in health care expenditure and rise in awareness about coronary heart diseases in countries such as Japan, China, and India.
The global angiography tables market is highly fragmented due to presence of major companies. Key players operating in the global market include AADCO Medical, Inc., ALVO Medical, Biodex, EMD Medical Technologies, Behyaar Sanaat Sepahan Co., Arcoma-IMIX, Control-X Medical, Ltd., Eurocolumbus, s.r.l., Knight Imaging, Intermedical S.r.l., and NOVAmedtek.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:

Neurological Disorder Diagnostic Market Competitive Landscape Analysis with Forecast by 2026

Global Neurological Disorder Diagnostic Market: Overview
The neurological disorder diagnostic devices are utilized to diagnosis of several neurological disorder like Multiple Sclerosis, Alzheimer’s disease (AD) and Parkinson’s disease (PD). Also, rising prevalence of neurological disorder in recent past likely to boost growth of the global neurological disorder diagnostic market.
As per report published in Parkinson Association of the Carolinas, close to 10 million people are suffering Parkinson disease. In addition, this account for around 60,000 case in the U.S. alone. As per data published by the Alzheimer’s association, approximately 5.5 million people of all age group people are suffering from Alzheimer’s dementia.
The report provide acute assessment of key growth drivers, trends, recent advancement in technology, the prevalent regulatory landscape, and the strategic dynamics in several regions during the course of forecast period of 2018–2026. The study detailed analysis into the emerging and current status of the market, key opportunities, and the promising avenues in different segments. The study can help players and stakeholders to identify imminent investment opportunity in this market.
Global Neurological Disorder Diagnostic Market: Trends and Opportunities
In recent years, the manufacturers have received approvals and has launched various technological advanced neurological disorder diagnostic device in the market. This is another factor fueling growth of this market in near future. The manufacturers are strategically partnering to develop new products related to neurological disorder diagnostics. This further contributes to the growth of this market in coming years. Rising adoption of neurological diagnostic device in hospitals and ambulatory care centers likely to propel market growth.
On the other hand, high cost associated with the diagnosis device such as CT scan and MRI scan likely to limit growth of the global neurological disorder diagnostic market. The high cost associated with the products leads to less adoption of products in emerging economies like China, India and Africa. These are some of the factor negatively impacting growth of this market at global level.
Global Neurological Disorder Diagnostic Market: Regional Outlook
On the geographical standpoint, North America dominate the global neurological disorder diagnostics market owing to high usage of these device by the hospital and ambulatory care centers in this region. On the other hand, Asia Pacific likely to register promising growth due to increasing demand for the neurological patients and growing healthcare infrastructure in this region.
Global Neurological Disorder Diagnostic Market: Companies Mentioned

The report offers key players operating in the global neurological disorder diagnostic market. Some of the prominent players operating in this market includes Canon Medical Systems Corporation, Healthineers, Masimo Corporation, Neusoft Medical Systems, and York Instruments Ltd. Merger and collaboration are the key strategic adopted by the major players in order to gain foothold and to achieve maximum share in the overall market.
Posted by at No comments:

Neonatal Intensive Care Respiratory Devices Market Growth Opportunities & Technology Developments by 2026

Global Neonatal Intensive Care Respiratory Devices Market – Snapshot
Neonatal respiratory care involves monitoring and treating newborn babies for breathing disorders. Newborn babies who need intensive care are often admitted to the NICU. The NICU has a range of equipment to take care of the babies, and respiratory devices play a vital role in treating respiratory disorders. However, demand for neonatal intensive care respiratory devices is anticipated to decline during the forecast period owing to high cost and technical errors in NICU devices.
The global neonatal intensive care respiratory devices market was valued at US$ 1,500 Mn in 2017 and is projected to expand at a CAGR of 5% from 2018 to 2026 to reach US$ 2,500 Mn by 2026. High incidence rate of respiratory diseases in newborn babies and increase in incidence of preterm births and corresponding efforts to improve survival rates are likely to fuel the growth of the global market from 2018 to 2026. Surge in government investment in health care infrastructure and strategic alliances among players to penetrate the emerging markets are expected to propel the global market during the forecast period.
There have been significant technological advancements in NICU devices for the treatment of various infectious diseases in the past few years. These devices offer affordable medical technologies and integration of various techniques in a single system. These factors fuel demand for advanced equipment in the NICU health care industry. In September 2018, Koninklijke Philips N.V., in collaboration with the Consortium for Affordable Medical Technologies (CAMTech), developed an innovative resuscitation device called AIR (Augmented Infant Resuscitator). It is an add-on device for conventional neonatal bag-valve-mask (BVM) resuscitators that effectively resuscitates asphyxiated newborns and helps reduce neonatal mortality. These advancements in NICU equipment are projected to boost to the market.
In terms of device type, the global neonatal intensive care respiratory devices market has been segmented into nebulizers, inhalers, ventilators, continuous positive airway pressure devices, apnea monitors, and others. The inhalers segment held the smallest market share in 2017. However, the segment is anticipated to expand at a high CAGR during the forecast period. Based on end-user, the global market has been classified into NICU hospitals, specialty clinics, nursing homes, and others. The NICU hospitals segment accounted for the largest market share in 2017. The segment is expected to expand at a significant CAGR during the forecast period.
North America is projected to account for major share of the global neonatal intensive care respiratory devices market from 2018 to 2026, supported by high cost of technologically advanced respiratory devices and rise in prevalence of premature births. Factors such as government initiatives to spread awareness about neonatal diseases and increase in R&D activities augment the market in the region. Moreover, high prices of products, rapid adoption of new devices, and increase in incidence of premature births in the U.S. boost the growth of the neonatal intensive care respiratory devices market in North America. A report published by the WHO in 2016 stated that the U.S. ranked sixth in the world in premature births. According to data released by the FDA (2016), nearly 6% of 4 million births in the U.S. each year requires NICU admission and majority of them is due to preterm birth.
The neonatal intensive care respiratory devices market in Asia Pacific is projected to expand at a high CAGR during the forecast period due to increase in focus on development of health care infrastructure by both public and private hospitals, high preterm rate, and surge in the number of NICU beds in countries such as South Korea and China. An article published in the Journal of Medical Systems in 2017 indicated that more than 3.5 million preterm births are recoded in India annually.
Key companies operating in the global neonatal intensive care respiratory devices market and profiled in the report include Getinge AB, Vyaire Medical, Inc. (BD), GE Healthcare, Teleflex Incorporated, Drägerwerk AG & Co. KGaA, Medtronic plc, Mercury Medical, Inspiration Healthcare Group plc, and Trudell Medical International.

Posted by at No comments:

Meniscal Repair Systems Market: Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2026

Meniscus plays an important role in human knee and has various functions such as shock absorption, load transmission across the knee joint, and joint nutrition. It occupies nearly 60% contact area between the tibial and femoral cartilage surfaces, contributing to knee joint stability and overall joint conformity. Meniscal tear is one of the common injuries caused during sports and athletics. Severe injury could require meniscus repair surgery. Various devices are used during the surgery such as inserters, depth probe, suture, and other instruments.
Rise in demand for meniscal repair systems, technological advancements such as automated deployment of sutures & development of miniaturized system, and increase in prevalence of orthopedic and trauma injuries are projected to drive the global meniscal repair systems market during the forecast period. Additionally, launch of new products by market players and increase in emphasis on sports and trauma injuries fuel the growth of the market. For instance, in May 2018, DePuy Synthes launched TRUESPAN Meniscal Repair System, a knee arthroscopy solution to simplify meniscal repair, thereby increasing the reach of arthroscopic procedures in countries in Europe, Middle East, & Africa (EMEA). In April 2018, Ceterix Orthopaedics received FDA approval for its NovoStitch Pro Meniscal Repair System, a next-generation meniscal repair system. The product represents the company’s innovative solution developed for arthroscopic knee repair which will enable it to achieve growth in the market. In April 2016, Zimmer Biomet acquired Cayenne Medical to achieve growth in its sports medicine segment.
The global meniscal repair systems market can be segmented based on component, indication, end-user, and region. In terms of component, the market can be divided into repair devices, depth probes, inserters, sutures, and others. The repair devices segment is projected to account for the largest market share during the forecast period due to rise in usage of repair devices for meniscal tear and increase in the number of companies offering meniscal repair devices. Based on indication, the global meniscal repair systems market can be classified into meniscal root tears, anterior cruciate ligament (ACL) injuries, and others. The meniscal root tears segment is anticipated to expand at the fastest CAGR during the forecast period due to increase in meniscal tears during sports and other recreational activities. In terms of end-user, the market can be categorized into hospitals, ambulatory surgical centers, and others. The hospitals segment is expected to account for the largest market share owing to increase in the number of orthopedic procedures and rise in patient pool.
The global meniscal repair systems market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest market share during the forecast period due to rise in emphasis on sports medicine and increase in the number of sports medicine and trauma care centers. The market in Europe is anticipated to grow at a rapid pace during the forecast period due to increase in the use of orthopedic surgical devices and high demand for technologically advanced meniscal repair systems in countries such as the U.K., Germany, and France. The market in Asia Pacific is expected to expand at the fastest CAGR during the forecast period, driven by rise in awareness about sports medicine, increase in the number of players focusing on emerging markets in Asia Pacific, and rise in geriatric population. The meniscal repair systems market in Middle East & Africa is driven by increase in the number of ambulatory care centers and strengthening health care systems in countries such as Saudi Arabia and the UAE.
Key players operating in the global meniscal repair systems market are Ceterix Orthopaedics, DePuy Synthes (Johnson & Johnson), Zimmer Biomet, Conmed Corporation, Arthrex, Stryker, Medtronic, BioTek Instruments, Inc., and Arcuro Medical Ltd.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Posted by at No comments:
Subscribe to: Posts (Atom)